Tongxinluo improves cardiac function and ameliorates ventricular remodeling in mice model of myocardial infarction through enhancing angiogenesis

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Bai, Wen Wu ^a,b   Xing, Yi Fan ^b   Wang, Bo ^b   Lu, Xiao Ting ^a   Wang, Ying Bin ^a   Sun, Yuan Yuan ^a,b   Liu, Xiao Qiong ^a,b   Guo, Tao ^a   Zhao, Yu Xia ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; TONGXINLUO; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DNA BINDING; FIBROSING ALVEOLITIS; GEL MOBILITY SHIFT ASSAY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEART VENTRICLE REMODELING; HISTOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIGATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84884261894     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/813247     Document Type: Article

References (34)

1. Go A. S., Mozaffarian D., Roger V. L., Heart disease and stroke statistics-2013 update: a report from the american heart association. Circulation 2013 127 1 6 245
2. Tao L., Wang Y., Gao E., Zhang H., Yuan Y., Lau W. B., Chan L., Koch W. J., Ma X. L., Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circulation Research 2010 106 2 409 417 2-s2.0-76349098660 10.1161/CIRCRESAHA.109.211797
3. Ding L., Dong L., Chen X., Zhang L., Xu X., Ferro A., Xu B., Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation 2009 120 9 764 773 2-s2.0-70349334413 10.1161/CIRCULATIONAHA.109.870725
4. Kupatt C., Hinkel R., Pfosser A., El-Aouni C., Wuchrer A., Fritz A., Globisch F., Thormann M., Horstkotte J., Lebherz C., Thein E., Banfi A., Boekstegers P., Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: role of vessel maturation. Journal of the American College of Cardiology 2010 56 5 414 422 2-s2.0-77955285388 10.1016/j.jacc.2010.03.050
5. Zhang L., Liu Y., Lu X. T., Wu Y. L., Zhang C., Ji X. P., Wang R., Liu C. X., Feng J. B., Jiang H., Xu X. S., Zhao Y. X., Zhang Y., Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy. American Journal of Physiology-Heart and Circulatory Physiology 2009 297 6 H2004 H2014 2-s2.0-72249115982 10.1152/ajpheart.00208.2009
6. Li X.-D., Yang Y.-J., Geng Y.-J., Jin C., Hu F.-A., Zhao J.-L., Zhang H.-T., Cheng Y.-T., Qian H.-Y., Wang L.-L., Zhang B.-J., Wu Y.-L., Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway. American Journal of Physiology-Heart and Circulatory Physiology 2010 299 4 H1255 H1261 2-s2.0-77958033698 10.1152/ajpheart.00459.2010
7. Liang J. Q., Wu K., Jia Z. H., Liu C., Ding J., Huang S. N., Yin P. P., Wu X. C., Wei C., Wu Y. L., Wang H. Y., Chinese medicine Tongxinluo modulates vascular endothelial function by inducing eNOS expression via the PI-3K/Akt/HIF-dependent signaling pathway. Journal of Ethnopharmacology 2011 133 2 517 523 2-s2.0-78651387773 10.1016/j.jep.2010.10.031
8. Meloni M., Caporali A., Graiani G., Lagrasta C., Katare R., Van Linthout S., Spillmann F., Campesi I., Madeddu P., Quaini F., Emanueli C., Nerve growth factor promotes cardiac repair following myocardial infarction. Circulation Research 2010 106 7 1275 1284 2-s2.0-77951298253 10.1161/CIRCRESAHA.109.210088
9. Kido M., Du L., Sullivan C. C., Li X., Deutsch R., Jamieson S. W., Thistlethwaite P. A., Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. Journal of the American College of Cardiology 2005 46 11 2116 2124 2-s2.0-28244446238 10.1016/j.jacc.2005.08.045
10. Zhou Y. C., Liu B., Li Y. J., Effects of buyang huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction. Evidence-Based Complement Alternative Medicine 2012 2012 11 385247 10.1155/2012/385247
11. Qin W. D., Wei S. J., Wang X. P., Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation. Biochimica et Biophysica Acta 2013 1833 1 59 68 10.1016/j.bbamcr.2012.10.013
12. Song W. T., Cheng F. F., Xu L., Lin C. R., Liu J. X., Chinese medicine shenfu injection to heart failure: a systematic review and meta-analysis. Evidence-Based Complement Alternative Medicine 2012 2012 25 713149 10.1155/2012/713149
13. Shao M. J., Wang S. R., Zhao M. J., The effects of velvet antler of deer on cardiac functions of rats with heart failure following myocardial infarction. Evidence-Based Complement Alternative Medicine 2012 2012 5 825056 10.1155/2012/825056
14. Ming X., Tong-shen W., Delin W., Ronghua Z., Cardioprotective effect of the compound Yangshen granule in rat models with acute myocardial infarction. Evidence-based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-84859739227 10.1155/2012/717123 717123
15. Chen W. Q., Zhong L., Zhang L., Ji X. P., Zhao Y. X., Zhang C., Jiang H., Wu Y. L., Zhang Y., Chinese medicine tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model. Journal of Ethnopharmacology 2009 124 1 103 110 2-s2.0-67349244318 10.1016/j.jep.2009.04. 009
16. Adluri R. S., Thirunavukkarasu M., Zhan L., Akita Y., Samuel S. M., Otani H., Ho Y.-S., Maulik G., Maulik N., Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice. Journal of Molecular and Cellular Cardiology 2011 50 1 239 247 2-s2.0-78650806850 10.1016/j.yjmcc.2010.11.002
17. Haider H. K., Akbar S. A., Ashraf M., Angiomyogenesis for myocardial repair. Antioxidants & Redox Signaling 2009 11 8 1929 1944 2-s2.0-67650251538 10.1089/ars.2009.2471
18. Samuel S. M., Akita Y., Paul D., Thirunavukkarasu M., Zhan L., Sudhakaran P. R., Li C., Maulik N., Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes 2010 59 1 51 60 2-s2.0-77449103235 10.2337/db09-0336
19. Wang Y., Ahmad N., Wani M. A., Ashraf M., Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. Journal of Molecular and Cellular Cardiology 2004 37 5 1041 1052 2-s2.0-7444246305 10.1016/j.yjmcc.2004.09.004
20. Patten R. D., Pourati I., Aronovitz M. J., Baur J., Celestin F., Chen X., Michael A., Haq S., Nuedling S., Grohe C., Force T., Mendelsohn M. E., Karas R. H., 17 β -estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circulation Research 2004 95 7 692 699 2-s2.0-4944237210 10.1161/01.RES.0000144126.57786.89
21. He Z., Opland D. M., Way K. J., Ueki K., Bodyak N., Kang P. M., Izumo S., Kulkarni R. N., Wang B., Liao R., Kahn C. R., King G. L., Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 4 787 793 2-s2.0-33646711638 10.1161/01.ATV.0000209500.15801.4e
22. Bárdos J. I., Ashcroft M., Negative and positive regulation of HIF-1: a complex network. Biochimica et Biophysica Acta 2005 1755 2 107 120 2-s2.0-22144493866 10.1016/j.bbcan.2005.05.001
23. Yang Y.-H., Wang Y., Lam K. S. L., Yau M.-H., Cheng K. K. Y., Zhang J., Zhu W., Wu D., Xu A., Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 5 835 840 2-s2.0-42149108104 10.1161/ATVBAHA.107.157776
24. Khan M., Varadharaj S., Ganesan L. P., Shobha J. C., Naidu M. U., Parinandi N. L., Tridandapani S., Kutala V. K., Kuppusamy P., C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. American Journal of Physiology-Heart and Circulatory Physiology 2006 290 5 H2136 H2145 2-s2.0-33646400545 10.1152/ajpheart.01072.2005
25. Schweppe R. E., Cheung T. H., Ahn N. G., Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responses. The Journal of Biological Chemistry 2006 281 30 20993 21003 2-s2.0-33746345001 10.1074/jbc.M604208200
26. Höpfl G., Wenger R. H., Ziegler U., Stallmach T., Gardelle O., Achermann R., Wergin M., Kaser-Hotz B., Saunders H. M., Williams K. J., Stratford I. J., Gassmann M., Desbaillets I., Rescue of hypoxia-inducible factor-1 α -deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Research 2002 62 10 2962 2970 2-s2.0-0037093107
27. Ong S. G., Hausenloy D. J., Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacology & Therapeutics 2012 136 1 69 81 10.1016/j.pharmthera.2012.07.005
28. Qing M., Görlach K., Schumacher K., Wöltje M., Vazquez-Jimenez J. F., Hess J., Seghaye M.-C., The hypoxia-inducible factor HIF-1 promotes intramyocardial expression of VEGF in infants with congenital cardiac defects. Basic Research in Cardiology 2007 102 3 224 232 2-s2.0-34250349948 10.1007/s00395-007-0654-3
29. Dimova E. Y., Michiels C., Kietzmann T., Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. Current Pharmaceutical Design 2009 15 33 3867 3877 2-s2.0-70649088038 10.2174/138161209789649358
30. Sumida A., Horiba M., Ishiguro H., Takenaka H., Ueda N., Ooboshi H., Opthof T., Kadomatsu K., Kodama I., Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovascular Research 2010 86 1 113 121 2-s2.0-77949419010 10.1093/cvr/cvp386
31. Hirota K., Semenza G. L., Regulation of angiogenesis by hypoxia-inducible factor 1. Critical Reviews in Oncology/Hematology 2006 59 1 15 26 2-s2.0-33745138232 10.1016/j.critrevonc.2005.12.003
32. Giacca M., Zacchigna S., VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Therapy 2012 19 6 622 629 2-s2.0-84857466981 10.1038/gt.2012.17
33. Kawasaki K., Smith R. S. Jr., Hsieh C. M., Sun J., Chao J., Liao J. K., Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Molecular and Cellular Biology 2003 23 16 5726 5737 2-s2.0-0041631006 10.1128/MCB.23.16.5726-5737.2003
34. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. M., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999 399 6736 601 605 2-s2.0-0033542476 10.1038/21224